Nicastrin Palmitoylation and Biology of Gamma Secretase
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
A2004104
Summary
Recent research efforts have uncovered a common thread that connects the effects of mutations in the proteins termed Presenilin 1, Presenilin 2 and the amyloid precursor protein (APP). All three mutant proteins increase the production of toxic beta-amyloid peptide (Aß), which accumulates in the brains of individuals with Alzheimer’s disease (AD). Dr. Thinakaran’s research seeks to gain new information regarding the molecules that play an essential role in the production of Aß peptides. Presenilins and a few other proteins act together to generate Aß by the enzymatic cleavage of amyloid precursor protein. Recently, specialized microdomains in the cell surface, called lipid raft, were found to be involved in the production of Aß. A better understanding of the relationship between Presenilin and associated proteins and lipid rafts will shed more light on the mechanisms involved in Aß production, and perhaps, lead to new therapeutic interventions for Alzheimer’s disease (AD).
Related Grants
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University